How can you Allocate Brand Marketing Budgets and Predict Return before you have Launched?

PRE-LAUNCH PRESSURE

Under pressure to deliver even higher profits from pharmaceutical brand launches?
How can you accurately predict the market share potential of a brand pre-launch?
How can you ensure you have maximum market share at launch and beyond?
How can you really know what the market drivers are for your brand before you launch?
How can you know which pharmaceutical marketing activities, and what budget allocations, will provide what return before launching your product?

THINGS TO CONSIDER ABOUT PRE-LAUNCH

Launch is a critical time for any pharmaceutical or biotech product. Some project and brand teams make a fundamental mistake early in their drugs' development lifecycles - they fail to adequately prepare the market for their products. As a result, recently, several new product launches have failed to grow as their companies had hoped. You know if you have been involved in one of these! During the 2 to 3 years leading up to a launch, product planners and marketing leaders must develop commercial launch plans that will maximize their product's commercial viability and allow the product to grow and thrive. In addition, they must ensure that the logistical aspects of the launch are managed expertly and in co-ordination with one another. Conducting such a complex array of strategic and tactical preparations can be extremely challenging and mistakes can be costly. Early-stage commercialization and market preparation deficiencies often are the result of insufficient or inadequate planning. Don't allow your product's commercial potential to falter.

Eularis have worked successfully during both pre-launch and launch of numerous pharmaceutical brands that continue to be category leaders due to the pre-launch analytics creating strong preparation for a successful launch.

PRE-LAUNCH QUESTIONS EULARIS CAN HELP YOU ANSWER

WHAT ARE THE PRE-LAUNCH AND LAUNCH PLANNING QUESTIONS EULARIS HAVE ANALYTICS TO SUPPORT AND REMOVE THE UNCERTAINTY SURROUNDING THE ANSWER?

PLANNING YOUR LAUNCH CAMPAIGN (Phase III +)
• What are the Key Market Drivers for my Therapeutic Category?
• What are the Strengths of my Competitor Brands and What are their Weaknesses to Exploit?
• What is the Best Way to Segment the Market for Maximum Sales?
• What is the Commercial Potential of our Market Category in a Specific Country?
• What is the Commercial Potential of my Brand with our Current Clinical Trial Data
• What is the Commercial Potential of my Brand with Additional Clinical Trial Data?
• What Price Point Will get us Maximum Sales?
• Which Country Should We Launch in First?
• How Should we Roll Out the Launch Across Countries?
• How Should we Position the Brand for Maximum Financial Impact?
• How Will We Know What Competitor Weaknesses We Can Exploit?

LATE-STAGE PRE-LAUNCH (Phase IV +)
• If We Stop Clinical Trials Now, What Will Be Our Launch Market Share?
• If We Do Further Clinical Trials, Will Our Launch Market Share be Impacted or Not?
• How Can We Know How to Speed up Approvals?
• How Can We Grow Patient Demand Without Being Able to Market the Drug?
• What are the Messages that are Drivers so We Know Which Messages will Drive Brand Growth the Most?
• Will Our Planned Messages Give Us Maximum Growth and, if not, Which Will?
• Have We Positioned the Brand to Capture Maximum Launch Market Share?
• How Can We Quantify the Potential Impact from Each Activity Before We Have Implemented Them?
• What are Our Optimal Sales and Marketing Activities and Allocations for Maximum Growth?
• How Can We Know How to Allocate Sales and Marketing Budgets Across Activities at Launch for a Specific Growth?
• How Do We Divide our Budgets Within These for Optimal Market Share and Sales Gain?

ANALYSIS OF LAUNCH STRATEGIES POST-APPROVAL
• Does Our Original Pricing and Reimbursement Planning Still Hold Up in Today's Environment?
• How should it be Amended?
• What is the Optimal Timing for Launch?
• How Can We Predict the Long-Term Brand Potential Analytics?
• How Can We Predict the Brand Launch Market Share and Sales Potential?
• How Much Market Share Should We Expect to Have at Launch Versus Competitors?
• Can We Do Marketing Mix Analytics in the Pre-Launch Stage to Reveal How, When and Where to Spend our Budget?

POST-LAUNCH QUESTIONS EULARIS CAN HELP YOU ANSWER

ANALYSIS OF LAUNCH STRATEGIES POST-LAUNCH
• How Can We Predict the Short-Term Success of our Drug Based Upon its Launch?
• How Can We Predict the Long-Term Success of a Drug Based Upon its Launch?
• How, When and Where Should we Spend our Budget across Sales Force and Promotional for Maximum Market Share Impact?
• What Are All the Factors Really Influencing Prescriber Behavior the Most?
• Which Messages are Having the Most Impact on Actual Prescribing?
• Can We Quantify the Financial Impact from each Individual Marketing Program?
• Which Elements of Each Program are Having the Most Actual Prescribing Impact?
• What is the Most Effective Mix of Sales and Promotional Activities for Optimal Market Share Growth
• How Can We Forecast Brand Performance Based on Investment Assumptions and Market Dynamics?
• What are the Rep Quality Differences Across Brands and Companies?
• How Can I Know Which Agencies Are the Best to Get the Most Financial Return?
• How Can We Optimize All Relevant Resources for our Brand and Portfolio Across Multiple Activities and Geographies?
• Have We Done Everything Right?

EULARIS' ANALYTICS ANSWERS ALL YOUR PRE-LAUNCH AND POST-LAUNCH DRUG BRAND QUESTIONS

Discover the answers to these questions and more by using Eularis 94.8 Pre-launch and Launch Planning Analytics for Predicting and Planning your Pharmaceutical Brand Marketing. Pre-launch Analytics is part of the advanced 94.8 Analytics System from Eularis and can help you in all the areas outlined above including:
• Quantify the Potential Impact from each Marketing Activity before Launch
• Evaluate which Messages will have the most Impact on actual Prescribing
• Reveal How, When and Where to Spend your Budget for the best Results
• Forecast Brand Performance at Launch based on the current situation
• A 'What If' Forecast showing the Impact of any specific Marketing Changes

IDEAL ANALYTICS USERS

Recognize your title below? If so, the 94.8 Pre-launch Analytics System would be ideal for your Pharmaceutical Marketing needs:
• VP Sales and Marketing
• Sales and Marketing Directors
• Commercial Directors
• Business Unit Managers
• Business Analytics Managers
• Business Intelligence Managers
• Group Brand Managers
• Senior Product Managers
• Senior Brand Managers
• Agency Directors needing to show ROI to their Pharma Brand Clients

CLIENT QUOTES

Powerful stuff. In my 20 years of marketing I have never seen such valuable data on my drug brands.' Specialist Team Leader, Pfizer

'It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions.' Brand Manager, GlaxoSmithKline

'It actually does what it says on the tin.' Business Intelligence Manager, Boehringer Ingelheim.

'Your system allowed us all to fully understand just how our overall company and its brands were perceived versus our competitors and what we were required to do in order to grow. Importantly, having a tool available that allowed us to predict whether or not our market share would grow or decline was invaluable as it allowed us for the first time to realistically evaluate our efforts and investments.' CEO, AstraZeneca

'We always had the problem that we had a lot of data but it still required guesswork and gut feeling to get us to our strategic marketing decisions. I wasn't sure you would be able to show me more than I already knew. However, this Workshop really showed me how to connect the data and the decisions and we now have repeatable improving sales results from implementing this!' Attendee from Eularis Workshop on ROI

PRE-LAUNCH PLANNING: Priming Your Pharmaceutical Brand For Profit And Success

Download Free Report Here

Only company email addresses are accepted for this so if you use your hotmail, yahoo, gmail, aol, comcast etc. email addresses, they will be rejected.

Your email address will be 100% protected and will never, ever be shared.

Only available to employees of Healthcare Companies including Pharmaceutical, Biotech, Medical Devices, Animal Health. If you have a Healthcare brand to market or sell, then you are likely to get in.